levofloxacin has been researched along with finafloxacin in 3 studies
Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (finafloxacin) | Trials (finafloxacin) | Recent Studies (post-2010) (finafloxacin) |
---|---|---|---|---|---|
4,346 | 581 | 2,209 | 16 | 4 | 15 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Jung, HC; Kim, JM; Kim, JS; Kim, N; Lee, DH; Lee, JW; Lee, SM; Nam, RH; Park, JY | 1 |
Dalhoff, A; Schubert, S; Vente, A | 1 |
Chalhoub, H; Harding, SV; Tulkens, PM; Van Bambeke, F | 1 |
3 other study(ies) available for levofloxacin and finafloxacin
Article | Year |
---|---|
High Efficacy of Finafloxacin on Helicobacter pylori Isolates at pH 5.0 Compared with That of Other Fluoroquinolones.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Asparagine; Aspartic Acid; DNA Gyrase; Female; Fluoroquinolones; Gene Expression; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Point Mutation; Treatment Outcome | 2015 |
Pharmacodynamics of Finafloxacin, Ciprofloxacin, and Levofloxacin in Serum and Urine against TEM- and SHV-Type Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae Isolates from Patients with Urinary Tract Infections.
Topics: Anti-Bacterial Agents; beta-Lactamases; Blood; Ciprofloxacin; Escherichia coli; Fluoroquinolones; Humans; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Urinary Tract Infections; Urine | 2017 |
Influence of pH on the activity of finafloxacin against extracellular and intracellular Burkholderia thailandensis, Yersinia pseudotuberculosis and Francisella philomiragia and on its cellular pharmacokinetics in THP-1 monocytes.
Topics: Anti-Bacterial Agents; Burkholderia; Fluoroquinolones; Francisella; Humans; Hydrogen-Ion Concentration; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Monocytes; THP-1 Cells; Yersinia pseudotuberculosis | 2020 |